Cabot Wealth Management’s bluebird bio BLUE Stock Holding History

Cabot Wealth Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,513	Closed	-$1.33M	–	146
2016 Q3	$1.33M	Sell	1,513 -94	-6%	-$68.1K	0.34%	84
2016 Q2	$901K	Sell	1,607 -26	-2%	-$14.7K	0.24%	90
2016 Q1	$899K	Sell	1,633 -36	-2%	-$22.1K	0.25%	82
2015 Q4	$1.39M	Sell	1,669 -971	-37%	-$970K	0.35%	84
2015 Q3	$2.92M	Buy	2,640 +827	+46%	+$1.51M	0.81%	50
2015 Q2	$3.96M	Sell	1,813 -561	-24%	-$1.14M	0.96%	43
2015 Q1	$3.71M	Buy	2,374 +118	+5%	+$156K	0.9%	46
2014 Q4	$2.68M	Buy	+2,256	New	+$1.51M	0.66%	68

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cabot Wealth Management's BLUE Position: Q4 2016 in Review

Cabot Wealth Management sold out of bluebird bio (BLUE) in Q4 2016, closing a stake of 1,513 shares — an estimated $1.33M sold.

Cabot Wealth Management first reported a position in BLUE in Q4 2014 and held it in 8 quarters. The position peaked at $3.96M in Q2 2015. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.

Cabot Wealth Management reported no remaining bluebird bio position as of Q4 2016 after selling out during the quarter.
Cabot Wealth Management sold 1,513 bluebird bio shares in Q4 2016, an estimated $1.33M.
Cabot Wealth Management first reported a position in bluebird bio in Q4 2014 and held it in 8 quarters.
Cabot Wealth Management's bluebird bio position peaked at $3.96M in Q2 2015.
199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.

Based on Cabot Wealth Management's 13F filing for Q4 2016, filed 7 Feb 2017.